US 11730150
Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy
granted A61KA61K49/0008
Quick answer
US patent 11730150 (Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K49/0008